 Your new post is loading...
Your new post is loading...
Scoop.it!
India News: After Bharat Biotech's Covaxin, another potential Covid-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod f... 
No comment yet.
Sign up to comment
Scoop.it!
Novel viruses have been emerging in CAFOs for years. Advocates say coronavirus should act as a wake-up call.
Scoop.it!
Dr.Gary Kobinger says there are more than 100 possible vaccines in development for COVID-19 around the world...
Scoop.it!
"This tells us that the basic organic chemistry needed for life is present in the raw gas prior to the formation of stars and planets."...
Scoop.it!
COVID-19 tests that have patients swab their own noses are as accurate as the more invasive tests that health care workers administer, a small study finds.
Scoop.it!
Outbreaks of influenza represent an important health concern worldwide. In many cases, vaccines are only partially successful in reducing the infection rate, and respiratory protective devices (RPDs) are used as a complementary countermeasure.
Scoop.it!
AstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII). The Company today reached a $750m agreement with CEPI and Gavi to support the manufacturing, procurement and distribution of 300 million doses of the vaccine, with delivery starting by the end of the year. In addition, AstraZeneca reached a licensing agreement with SII to supply one billion doses for low and middle-income countries, with a commitment to provide 400 million before the end of 2020. Together, the agreements mark the latest commitments to enable global access to the vaccine, including to low and middle-income countries, beyond AstraZeneca’s recent partnerships with the UK and US.
Scoop.it!
Johnson & Johnson is planning to enroll more than 1,000 volunteers in the US and Belgium starting in July to test its vaccine.
Scoop.it!
Have policies aimed at avoiding COVID-19 infections worked?"I don't think any human endeavor has ever saved so many lives in such a short period of time."...
Scoop.it!
Emergent BioSolutions Inc. announced Thursday it signed an agreement to provide its contract development and manufacturing (CDMO) services to support AstraZeneca’s COVID-19 vaccine candidate in the United States.
Scoop.it!
The rush to develop a vaccine for COVID-19 has extended to Italy and Israel, where scientists are using the tools of genetic engineering to develop algae-based edible vaccines against the disease caused by the novel coronavirus.
|
Scoop.it!
The evolutionary dynamics of a virus can differ within hosts and across populations. Studies of within-host evolution provide an important link between experimental studies of virus evolution and l...
Scoop.it!
Regeneron Pharmaceuticals has commenced the first clinical trial of its dual antibody cocktail, REGN-COV2, which is meant to prevent and treat Covid-19.
Scoop.it!
Sinovac Biotech announced preliminary study results showing its experimental Covid-19 vaccine generated immune responses in patients and was safe.
Scoop.it!
Asymptomatic transmission ‘is the Achilles’ heel of COVID-19 pandemic control,’ one study says.
Scoop.it!
Experts continue warning about the devastating effects of a second wave of coronavirus cases, but a top U.S. health official says it will be even worse if Americans don’t get a flu shot.
tarek11223344's curator insight,
June 24, 2020 4:14 AM
In newly times, modern consumers have never-ending options in front of them when it comes to choosing new products, brands, or services. This means that the customer’s hope are greatly high in the present time. Share your opinionfor amazing rewards
Scoop.it!
Experts call for large-scale viral testing in children, contract tracing, and other actions to avoid compounding the COVID-19 crisis as schools reopen.
Alicyn Benton's curator insight,
June 25, 2020 12:21 AM
This topic definitely needs to be checked into with additional precautions! I say that due to schools not being able to dictate parents sending their children to school. We can always say please don’t send your children if they are sick and they still do. This will then put not only other students but faculty members at risk.
Scoop.it!
All neurological manifestations UK-wide surveillance of neurological and neuropsychiatric complications of COVID19 the first 153 patients. Preprint Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.
Scoop.it!
Among 12- to 23-month-olds who received their first dose of measles-containing vaccine, fever and seizure were elevated 7 to 10 days after vaccination. Vaccination with MMRV results in 1 additional febrile seizure for every 2300 doses given instead of separate MMR + varicella vaccines.
Scoop.it!
In less than 6 months, the severe acute respiratory syndrome‐coronavirus type 2 (SARS‐CoV‐2) has spread worldwide infecting nearly 6 million people and killing over 350,000. Initially thought to be...
Scoop.it!
Beijing has mobilized its health authorities, drug regulators and research institutes to work around the clock with local companies to come up with the world’s first effective vaccine for Covid-19.
Scoop.it!
OTTAWA — One of Canada's preeminent infectious disease experts says he is confident a vaccine for COVID-19 will be ready in months, not years.Dr. Gary Kobinger, director of the Research Centre on . . .
Scoop.it!
While large companies and public sector consortiums in the United States, Canada, China and Europe are running at full speed to develop a vaccine grown in genetically modified (GM) tobacco plants, a research group at a Mexican university is working toward the same objective, but with a different and innovative strategy. They are using bioinformatics …
|
